NCT06534814View on ClinicalTrials.gov

Development and Application of an Artificial Intelligence-driven Accurate Identification Model for Gastric Cancer Lymph Node Metastasis

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

July 30, 2030

Conditions
The Primary Focus of This Study is on Gastric Cancer
Interventions
DIAGNOSTIC_TEST

AI-Driven Identification Model for Gastric Cancer Lymph Node Metastasis (AID-GLNM)

The AI-Driven Identification Model for Gastric Cancer Lymph Node Metastasis (AID-GLNM) intervention involves the development and application of an advanced artificial intelligence (AI) system specifically designed to enhance the identification and characterization of lymph node metastasis in patients diagnosed with gastric cancer.

Trial Locations (1)

050011

RECRUITING

Department of General Surgery, Shijiazhuang

All Listed Sponsors
lead

Hebei Medical University

OTHER